Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelli...
Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, has reached a research milestone of o...
William Blair initiated coverage on Tempus AI, highlighting its unique approach and business model in healthcare technology. Th...
B of A Securities analyst Michael Ryskin initiates coverage on Tempus AI (NASDAQ:TEM) with a Buy rating and announces Price ...
Tempus AI provides advanced technology to the healthcare and diagnostics market, which is expected to grow at +30%.
William Blair analyst Andrew Brackmann initiates coverage on Tempus AI (NASDAQ:TEM) with a Outperform rating.
JP Morgan analyst Rachel Vatnsdal initiates coverage on Tempus AI (NASDAQ:TEM) with a Overweight rating and announces Price ...
Loop Capital analyst Mark Schappel initiates coverage on Tempus AI (NASDAQ:TEM) with a Buy rating and announces Price Target...
